CONCORD BIOTECH
Quarterly Results Analysis [Mar2025]
CONCORD BIOTECH Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹430 Cr | ₹244 Cr | ₹310 Cr | ₹216 Cr | ₹319 Cr | ₹241 Cr | ₹262 Cr | ₹195 Cr |
Expenses | ₹239 Cr | ₹146 Cr | ₹174 Cr | ₹135 Cr | ₹185 Cr | ₹135 Cr | ₹143 Cr | ₹123 Cr |
Operating Income | ₹190 Cr | ₹98 Cr | ₹137 Cr | ₹81 Cr | ₹134 Cr | ₹106 Cr | ₹119 Cr | ₹72 Cr |
Other Income | ₹9 Cr | ₹15 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
Profit Before Tax | ₹185 Cr | ₹99 Cr | ₹133 Cr | ₹78 Cr | ₹131 Cr | ₹100 Cr | ₹113 Cr | ₹65 Cr |
Profit After Tax | ₹142 Cr | ₹74 Cr | ₹99 Cr | ₹58 Cr | ₹97 Cr | ₹75 Cr | ₹84 Cr | ₹48 Cr |
EPS | ₹13.42 | ₹7.26 | ₹9.15 | ₹5.70 | ₹9.08 | ₹7.41 | ₹7.74 | ₹5.21 |
Industry Peers & Returns | 1W | 1M | 1Y |
CONCORD BIOTECH | -6.7% | 29.5% | 32.7% |
SUN PHARMACEUTICAL INDUSTRIES | -2.5% | -4.9% | 8.7% |
DIVIS LABORATORIES | -2.7% | -0.9% | 42.5% |
CIPLA | -1.5% | 0.1% | -4.3% |
TORRENT PHARMACEUTICALS | -2.6% | -3.7% | 11.9% |
DR REDDYS LABORATORIES | -2.6% | 8.3% | 7.9% |
MANKIND PHARMA | -2.5% | -8.3% | 5.2% |
ZYDUS LIFESCIENCES | -2.6% | 6.8% | -13.6% |
LUPIN | -3.4% | -3.2% | 21.8% |
CONCORD BIOTECH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 76.02 % |
Y-o-Y | 34.77 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹430 Cr | 76.02 | |
Dec2024 | ₹244 Cr | -21.27 | |
Sep2024 | ₹310 Cr | 43.73 | |
Jun2024 | ₹216 Cr | -32.34 | |
Mar2024 | ₹319 Cr | 32.46 | |
Dec2023 | ₹241 Cr | -8.21 | |
Sep2023 | ₹262 Cr | 34.66 | |
Jun2023 | ₹195 Cr | - |
CONCORD BIOTECH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 94.40 % |
Y-o-Y | 41.80 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹190 Cr | 94.40 | |
Dec2024 | ₹98 Cr | -28.33 | |
Sep2024 | ₹137 Cr | 68.16 | |
Jun2024 | ₹81 Cr | -39.47 | |
Mar2024 | ₹134 Cr | 26.77 | |
Dec2023 | ₹106 Cr | -11.13 | |
Sep2023 | ₹119 Cr | 65.19 | |
Jun2023 | ₹72 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.45 % |
Y-o-Y | 5.23 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 44.3% | 10.45 | |
Dec2024 | 40.11% | -8.97 | |
Sep2024 | 44.06% | 16.99 | |
Jun2024 | 37.66% | -10.55 | |
Mar2024 | 42.1% | -4.30 | |
Dec2023 | 43.99% | -3.17 | |
Sep2023 | 45.43% | 22.68 | |
Jun2023 | 37.03% | - |
CONCORD BIOTECH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 91.57 % |
Y-o-Y | 46.00 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹142 Cr | 91.57 | |
Dec2024 | ₹74 Cr | -24.93 | |
Sep2024 | ₹99 Cr | 69.47 | |
Jun2024 | ₹58 Cr | -40.09 | |
Mar2024 | ₹97 Cr | 30.39 | |
Dec2023 | ₹75 Cr | -11.76 | |
Sep2023 | ₹84 Cr | 74.32 | |
Jun2023 | ₹48 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 8.83 % |
Y-o-Y | 8.33 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 33.02 % | 8.83 | |
Dec2024 | 30.34 % | -4.65 | |
Sep2024 | 31.82 % | 17.90 | |
Jun2024 | 26.99 % | -11.45 | |
Mar2024 | 30.48 % | -1.55 | |
Dec2023 | 30.96 % | -3.88 | |
Sep2023 | 32.21 % | 29.46 | |
Jun2023 | 24.88 % | - |
CONCORD BIOTECH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 84.85 % |
Y-o-Y | 47.80 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹13.42 | 84.85 | |
Dec2024 | ₹7.26 | -20.66 | |
Sep2024 | ₹9.15 | 60.53 | |
Jun2024 | ₹5.7 | -37.22 | |
Mar2024 | ₹9.08 | 22.54 | |
Dec2023 | ₹7.41 | -4.26 | |
Sep2023 | ₹7.74 | 48.56 | |
Jun2023 | ₹5.21 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD